Opportunistic Infections in Biological Therapy, Risk and Prevention

This publication has 72 references indexed in Scilit:

• Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study
  Annals of the Rheumatic Diseases, 2014
• Biologic Therapies in Rheumatoid Arthritis and the Risk of Opportunistic Infections: A Meta-analysis
  Clinical Infectious Diseases, 2014
• A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease
  Journal of Gastroenterology, 2012
• Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs
  Seminars in Arthritis and Rheumatism, 2012
• Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
  Annals of the Rheumatic Diseases, 2011
• Adverse effects of biologics: a network meta-analysis and Cochrane overview
  Cochrane Database of Systematic Reviews, 2011
• Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
  American Journal of Gastroenterology, 2009
• Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
  Gastroenterology, 2008
• T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection
  Trends in Molecular Medicine, 2004
• Perturbation of the T cell repertoire in rheumatoid arthritis
  Proceedings of the National Academy of Sciences, 1998